HOPKINTON, Mass., Dec. 12 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. , today announced expanded sales of its LabChip(R) and IVIS(R) drug discovery and development systems to top-tier customers including Pfizer, AstraZeneca, and Momenta Pharmaceuticals. These systems help scientists accelerate and improve drug discovery and development.
Caliper's LabChip and IVIS systems connect research data from in vitro experimentation (outside a living organism) to in vivo experimentation (inside a living organism), while providing the highest precision, efficiency and quality of data. By connecting in vivo and in vitro experimentation, researchers are better able to predict human outcomes and reduce drug candidate attrition. Caliper's portfolio of offerings provides the pharmaceutical industry with the technology and support to improve clinical relevance and more rapidly develop effective treatments for disease.
"With the Caliper name supporting the IVIS imaging system, we are seeing rapid adoption in the commercial sector," said Kevin Hrusovsky, CEO of Caliper Life Sciences. "The sales of both products are representative of Caliper's ability to meet the needs and demands of the industry while fostering the company's own growth and strategic direction as a leading provider of in vitro and in vivo drug discovery and development technologies."
About Caliper Life Sciences
Caliper Life Sciences is a leading provider of drug discovery and life sciences research solutions for the pharmaceutical and biotechnology industries. With its acquisitions of NovaScreen Biosciences and Xenogen Corporation, Caliper has positioned itself to transform drug discovery and development through a keen focus on clinically relevant experimentation. Caliper's products and services, assembled from a leading portfolio of microfluidics, liquid handling, and imaging technologies, span in vitro and in vivo experimentation and address key issues on the critical path of drug discovery and development. More information about Caliper can be found at www.caliperLS.com .
NOTE: Caliper, Xenogen, IVIS and LabChip are registered trademarks of Caliper Life Sciences, Inc.
Caliper Life Sciences, Inc.CONTACT: Michele Boudreau of Caliper Life Sciences, Inc., +1-650-279-2088;or Stacey Holifield, or Melissa Bruno, both of Schwartz Communications, forCaliper Life Sciences, Inc., +1-781-684-0770, or caliper@schwartz-pr.com
Web site: http://www.caliperLS.com/
